These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas]. Kenis Y; Piccart M; Beer M Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477 [No Abstract] [Full Text] [Related]
7. [Tumors of ovary and testis (author's transl)]. De Jager R Rev Med Brux; 1980 May; 1(5):315-20. PubMed ID: 6258206 [No Abstract] [Full Text] [Related]
8. Etoposide salvage therapy for refractory germ cell tumors: an update. Williams SD; Einhorn LH Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056 [No Abstract] [Full Text] [Related]
9. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance. Al-Obaidy KI; Chovanec M; Cheng L Expert Rev Anticancer Ther; 2020 Feb; 20(2):75-79. PubMed ID: 31951790 [No Abstract] [Full Text] [Related]
10. Cisplatin-related Cerebral Infarction in Testicular Germ Cell Cancer: Short Report of Three Cases and P in testicular germ cell cancer: Short report of three cases and pathomechanism. Lange J; Audebert HJ; Endres M; Rocco A Clin Neurol Neurosurg; 2017 Jan; 152():76-77. PubMed ID: 27923208 [No Abstract] [Full Text] [Related]
11. Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life. Nichols C; Kollmannsberger C J Natl Cancer Inst; 2010 Aug; 102(16):1214-5. PubMed ID: 20631340 [No Abstract] [Full Text] [Related]
12. Re: Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. Richie JP J Urol; 2013 Nov; 190(5):1767-8. PubMed ID: 24120784 [No Abstract] [Full Text] [Related]
13. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial. Drasga RE; Williams SD; Einhorn LH; Birch R Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247 [No Abstract] [Full Text] [Related]
15. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours? Pizzocaro G; Guarneri A Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203 [No Abstract] [Full Text] [Related]
16. In germ cell cancer, are we at the end of the chemotherapy era? Maybe--and we are certainly at the end of the RCT era. Maroni P Oncology (Williston Park); 2013 Nov; 27(11):1136, 1143. PubMed ID: 24575541 [No Abstract] [Full Text] [Related]
18. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group. Williams SD; Birch R; Gams R; Irwin L Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593 [No Abstract] [Full Text] [Related]